Archean Chemical Industries LtdQ1 FY25
Archean Chemical Industries Ltd Q1 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹522P/E: 62.1Market Cap: ₹6.6K CrSector: Chemicals & Petrochemicals
Management growth scorecard
Revenue
Category 2
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 2- →**Bromine volumes for FY '26:** Targeted increase to 22,000 - 25,000 tons (including captive consumption), surpassing FY '25 volumes of ~18,000 tons.
- →**Bromine derivatives:** Targeting at least 10,000 tons sales in FY '26, with a strong start of 500 tons sold in Q4 FY '25, indicating potential upside.
- →**Industrial Salt volumes for FY '26:** Expected to exceed 4 million tons, with capacity expanded to over 5 million tons annually after commissioning of additional washery.
- →**Revenue from Oren Hydrocarbons:** Estimated INR 150 crores for FY '26, with peak potential previously near INR 500 crores pre-troubles.
- →**Pricing outlook:** Salt prices largely stable with occasional minor drops; bromine pricing expected to maintain or modestly increase with long-term contracts priced about 20% below spot rates.
- →**Strategic growth:** Focus on bromine and derivatives expansion, plus new initiatives in semiconductor and energy storage sectors supporting long-term growth.
Margin guidance
Category 3- →Bromine volumes targeted to increase to 22,000-25,000 tons in FY '26, with growing demand and contracts underpinning confidence.
- →Bromine derivative business aims to achieve positive PAT this year, indicating expected profitability improvement.
- →Industrial salt volumes expected to maintain above 1 million tons per quarter with tight cost control sustaining contribution levels.
- →Sulphate of Potash plant scale-up anticipated to contribute meaningfully from second half FY '26.
- →Margins expected to improve as bromine derivative plant utilization rises beyond 50% in near term.
- →Modest capex planned (~INR 50-60 crores) for semiconductor project next year; focus on disciplined capital allocation.
- →Overall EBITDA margin stable around 35% in FY '25; efforts ongoing to sustain or improve through volume growth and cost management.
- →Net profit for FY '25 was INR 1,849.2 million with optimism on increasing top line and bottom line through volume growth, new products, and operational efficiencies.
3 more insights locked — sign up free to unlock
Fundraise plans
- →No specific mention of any new fundraising through debt or equity in the call transcript.
- →The company stated it remains a net debt-free entity with a strong balance sheet.
- →Capital allocation is described as disciplined, focusing on cautious and conservative use of cash.
- →Current and planned capital expenditures are funded within existing budgets (e.g., bromine derivatives project under INR250 crores, Oren Hydrocarbons refurbishment within INR25-30 crores budget).
- →No large incremental capex or new external financing planned outside these budgets.
- →Ongoing projects like the semiconductor initiative and energy storage are progressing with existing resources.
- →The management emphasizes vigilance and prudence in pursuing growth opportunities without indicating plans for fresh debt or equity raising.
Order book
- →The transcript does not explicitly mention the current or expected order book or pending orders for Archean Chemical Industries Limited.
- →However, management highlighted strong contracts for bromine with visibility on growth for FY '26 (targeting 22,000 to 25,000 tons in sales).
- →Long-term bromine contracts continue without price reductions, indicating stability and ongoing demand.
- →Industrial salt sales have recovered strongly with volumes reaching 1.3 million tons in Q4 FY '25 and capacity expanded to over 5 million tons annually, supported by long-term customer contracts.
- →The derivatives business, though in early stages, shows promise with 500 MT sold in Q4 FY '25 and a target of 10,000 MT for FY '26.
- →Oren Hydrocarbons are operational in parts with revenues expected around INR 150 crores this year, indicating growing business from the acquired asset.
Capex plans
Yes- →Bromine derivatives business: Total planned capex of around INR250 crores; INR160-170 crores already spent. Additional capex for flame retardant project within the original budget; commissioning expected by FY '26 end.
- →Oren Hydrocarbons: Acquisition cost approximately INR77 crores plus ~INR10 crores refurbishment. Total budgeted capex INR25-30 crores; no large incremental capex planned beyond this.
- →SOP (Sulphate of Potash) plant startup: Estimated capex of INR20-30 crores expected between now and September-October.
- →Semiconductor project: Land acquisition completed; major capex planned for next year, with INR50-60 crores capex possibly in FY '26.
- →Offgrid Energy Labs (zinc-bromide battery business): Progressing on site and vendor selection; no large capex currently.
- →Salt business: No major capex except for routine maintenance and operational scale-up.
How does Archean Chemical Industries Ltd rank vs peers in Chemicals & Petrochemicals?
Pro feature1Archean Chemical Industries Ltd
Rev 2Mar 3
See full Chemicals & Petrochemicals sector rankings
Want more stocks like Archean Chemical Industries Ltd?
Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.
Build my portfolio